Protara Therapeutics (TARA) Times Interest Earned (2013 - 2026)
Protara Therapeutics' (TARA) quarterly Times Interest Earned came in at -$2.22 in Q1 2026, up 33.61% year-on-year from -$1.66 in Q1 2025, and up 95.85% on a QoQ basis from -$53.44 in Q4 2025.
Protara Therapeutics (TARA) Times Interest Earned (2013 - 2026) Analysis & Trends
Protara Therapeutics (TARA) has 14 years of Times Interest Earned data on file, last reported at -$2.22 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 33.61% year-over-year to -$2.22 in Q1 2026; TTM through Mar 2026 was -$7.92, a 34.92% increase from a year earlier, with the FY2025 full-year figure at -$0.77, down 13.88% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$2.22, up from -$53.44 in the prior quarter.
- Over the last five years, Times Interest Earned for TARA reached as high as -$2.22 in Q1 2026 and fell as low as -$119.0 in Q4 2022.
- Historically, Times Interest Earned has averaged -$21.54 across 5 years, with a median of -$7.01 in 2022.
- On a YoY basis, Times Interest Earned climbed as much as 97.45% in 2022 and fell as far as 2565.33% in 2022.
- Year by year, Times Interest Earned stood at -$119.0 in 2022, then surged by 61.18% to -$46.2 in 2023, then grew by 6.68% to -$43.11 in 2024, then declined by 23.97% to -$53.44 in 2025, then soared by 95.85% to -$2.22 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$2.22 in Q1 2026, -$53.44 in Q4 2025, and -$2.92 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Protara Therapeutics | 2.25 Mn | 2.25 Mn | - | -2.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.22 |
| Dec 31, 2025 | -53.44 |
| Sep 30, 2025 | -2.92 |
| Jun 30, 2025 | -3.79 |
| Mar 31, 2025 | -3.34 |
| Dec 31, 2024 | -43.11 |
| Sep 30, 2024 | -2.29 |
| Jun 30, 2024 | -7.46 |
| Mar 31, 2024 | -3.22 |
| Dec 31, 2023 | -46.20 |
| Sep 30, 2023 | -7.67 |
| Jun 30, 2023 | -8.50 |
| Mar 31, 2023 | -29.31 |
| Dec 31, 2022 | -119.00 |
| Sep 30, 2022 | -5.53 |
| Jun 30, 2022 | -6.56 |
| Dec 31, 2021 | -4.46 |
| Sep 30, 2021 | -216.60 |
| Jun 30, 2021 | -220.55 |
| Mar 31, 2021 | -176,363.64 |